Navigation Links
BioMarin Announces the Planned Retirement of Dr. Emil Kakkis, Chief Medical Officer
Date:11/21/2008

e Harbor-UCLA Medical Center, Division of Genetics, Department of Pediatrics. Together with his colleague Elizabeth F. Neufeld, Ph.D., of the University of California at Los Angeles (UCLA), Dr. Kakkis discovered how to produce a recombinant form of alpha-L-iduronidase (later to become known as Aldurazyme(R) [laronidase]), the enzyme which people with mucopolysaccharidosis I (MPS I) are lacking. While at BioMarin, Dr. Kakkis was instrumental in guiding Aldurazyme, Naglazyme and Kuvan through development and regulatory approval. He also drove initial phases of development of PEG-PAL pre-clinical, clinical, regulatory and research organizations.

The company is initiating a search for a new Chief Medical Officer. It hopes to have a new Chief Medical Officer by the end of the first quarter of 2009.

About BioMarin

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises three approved products and multiple clinical and pre-clinical product candidates. Approved products include Naglazyme(R) (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme(R) (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; and Kuvan(R) (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany. Other product candidates include 6R-BH4 for cardiovascular indications, which is currently in Phase 2 clinical development for the treatment of peripheral arterial disease and sickle cell disease, and PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase), which is currently in Phase 1 clinical development for the treatment of PKU. For additional information, ple
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
2. BioMarin to Present at the BioCentury NewsMakers Conference
3. BioMarin to Present at the Rodman & Renshaw 9th Annual Healthcare Conference
4. BioMarin and IGAN Biosciences to Collaborate on Development of an Enzyme Therapy to Treat IgA Nephropathy, a Rare and Life-Threatening Kidney Disease
5. BioMarin and Genzyme Restructure Aldurazyme 50/50 Joint Venture
6. BioMarin Appoints Dr. Gordon Vehar, Vice President of Research
7. BioMarin to Present at the Merrill Lynch 2008 Global Healthcare Conference
8. BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results
9. BioMarin to Host First Quarter 2008 Financial Results Conference Call and Webcast on Tuesday, April 29 at 5:00 p.m. ET (23:00 CET)
10. BioMarin to Present at the Morgan Stanley Healthcare Conference
11. BioMarin Announces First Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... September 17, 2014 Beckman Coulter ... science and healthcare, has renewed its agreement with ... part of the agreement, Personify will continue to streamline ... emphasis on recruitment analytics, including time-to-fill, time-to-source and a ... our agreement with Personify was based on the success ...
(Date:9/17/2014)... The Pistoia Alliance, a global ... barriers to innovation in life sciences R&D through ... Nitsche as Executive Director Business Development North America, ... reach. , Carmen joins the Pistoia Alliance from ... At Accelrys, she managed various life sciences and ...
(Date:9/16/2014)... from jaw movements has been created by a group ... the device can generate electricity from eating, chewing and ... wearable electronic devices, such as hearing aids, cochlear implants, ... results of the device,s performance have been published today, ... and Structures . , Jaw movements have proved to ...
(Date:9/16/2014)... Rice University scientists who created a deicing film for ... as a transparent coating for glass. , The ... colleagues could keep glass surfaces from windshields to skyscrapers ... to radio frequencies (RF). , The technology was ... Applied Materials and Interfaces . , The ...
Breaking Biology Technology:Beckman Coulter Signs 3-year RPO Contract with Personify 2Beckman Coulter Signs 3-year RPO Contract with Personify 3Pistoia Alliance Expands Business Development with Appointment of Carmen Nitsche 2'Smart material' chin strap harvests energy from chewing 2Nanoribbon film keeps glass ice-free 2
... New, freely ... capture system , ... MA (PRWEB) May 10, 2010 -- Akaza Research announces the availability of the OpenClinica ... helps OpenClinica users find, share, and re-use clinical trial case report forms. It contains a ...
... GUANGZHOU, China , May 10 /PRNewswire-Asia/ -- China Medicine ... China of Western pharmaceuticals, traditional Chinese medicine,products, other nutraceuticals, medical devices, ... 9:00 a.m. Eastern,Time on Thursday, May 13, 2010 ... , , ...
... May 10 Fate Therapeutics, Inc. ... vice president of research and drug discovery.  Dr. Novak brings ... large pharmaceutical companies, including Roche and Wyeth, to apply transformative ... Novak will be responsible for Fate,s drug discovery and development ...
Cached Biology Technology:OpenClinica Case Report Form Library Now Available 2OpenClinica Case Report Form Library Now Available 3OpenClinica Case Report Form Library Now Available 4China Medicine Announces Conference Call to Discuss First Quarter 2010 Results 2Fate Therapeutics Appoints Tom Novak, Ph.D., as Vice President of Research and Drug Discovery 2Fate Therapeutics Appoints Tom Novak, Ph.D., as Vice President of Research and Drug Discovery 3
(Date:9/17/2014)... Campaigns against disposable plastic shopping bags and their environmental ... lawmakers passed the first statewide ban on the bags, ... But the plastic bag industry is not yielding without ... & Engineering News , the weekly newsmagazine of the ... with C&EN, reports that the anti-bag campaign logged its ...
(Date:9/17/2014)... Oncology-Bellvitge Biomedical Research Institute (ICO-IDIBELL), led by David ... normal accompanying cells in colorectal tumors. Analysis of ... tumors, predict the evolution of the patient and ... , Biomarkers , Colorectal cancer ... both sexes. About 30,000 new cases are diagnosed ...
(Date:9/17/2014)... [Brown University] After decades of decline, grasses have ... To the eye, the marsh in those places seems ... a key service of the marsh coastal protection ... but the ecosystem function hasn,t come back," said ecologist ... author of the study in the journal Biological ...
Breaking Biology News(10 mins):Five genes to predict colorectal cancer relapses 2Cape Cod saltmarsh recovery looks good, falls short 2Cape Cod saltmarsh recovery looks good, falls short 3
... Even moderate thyroid dysfunction during early pregnancy significantly increases ... universal screening in the first trimester, a new study ... Endocrine Society,s 94th Annual Meeting in Houston. "These ... studies that all pregnant women, irrespective of their risk ...
... Gallagher and his wife, Elizabeth, have made a $5 ... Family Professorships in Adult Stem Cell Research at the ... fund three new endowed professorships in adult and all ... Dame,s leadership in the field of stem cell research ...
... An elementary school science activity asks children who have each ... with string and tape to other "organisms" their assigned plant ... ecosystem web has been created, the teacher describes an event ... Other "organisms" that feel the tug then tug on their ...
Cached Biology News:Mild thyroid dysfunction in early pregnancy linked to serious complications 2Notre Dame establishes professorships in adult stem cell research 2Notre Dame establishes professorships in adult stem cell research 3Foundational concept of ecology tested by experiment 2Foundational concept of ecology tested by experiment 3Foundational concept of ecology tested by experiment 4
The Light Diagnostics Calicivirus Genotype 1&2 Typing OligoDetect assay is applicable for the qualitative detection of calicivirus RNA generated by an in-house validated in vitro nucleic acid amplifi...
X-Gal...
Recombinant Rat CINC-2 alpha, CF...
RABBIT ANTI SRC-RSV...
Biology Products: